Evelo Biosciences, Inc.
EVLO · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $140 | $321 | $477 | $130 |
| - Cash | $48 | $68 | $69 | $78 |
| + Debt | $51 | $56 | $40 | $20 |
| Enterprise Value | $144 | $309 | $448 | $72 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$106 | -$115 | -$90 | -$84 |
| % Margin | – | – | – | – |
| Net Income | -$115 | -$122 | -$94 | -$86 |
| % Margin | – | – | – | – |
| EPS Diluted | -26.28 | -46.18 | -47.45 | -53.49 |
| % Growth | 43.1% | 2.7% | 11.3% | – |
| Operating Cash Flow | -$101 | -$97 | -$73 | -$72 |
| Capital Expenditures | -$1 | -$2 | -$1 | -$3 |
| Free Cash Flow | -$102 | -$98 | -$74 | -$75 |